Hemostasis: A practical review of conservative and operative care

Clinical Orthopaedics and Related Research

Volumn 328, Issue , 1996, Pages 34-38

  Shopnick, Rinah I ^a,b   Brettler, Doreen B ^a  

^a Med Center of Central Massachusetts   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; DESMOPRESSIN; DESMOPRESSIN ACETATE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTHROMBIN;

ARTHRITIS; BLEEDING; BLOOD BANK; BLOOD CLOTTING FACTOR DEFICIENCY; CONSERVATIVE TREATMENT; FLUSHING; HEADACHE; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SYNOVITIS; TACHYPHYLAXIS;

EID: 0029900848     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199607000-00008     Document Type: Review

References (39)

1. Birch NC, Ribbans WJ, Goldman E, Lee CA: Knee replacement in hemophilia. Letter. J Bone Joint Surg 76B:165, 1994.
2. Brettler DB, Forsberg AD, Levine PH, et al: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. Arch Intern Med 149:1381-1385, 1989.
3. Brettler DB, Forsberg AD, Levine PH, et al: Factor VIII-.C concentrate purified from plasma using monoclonal antibodies: Human studies. Blood 73:1859-1863, 1989.
4. Brettler DB, Levine PH: Factor concentrates for treatment of hemophilia: Which one to choose? Blood 73:2067-2073, 1989.
5. Brown DC: Adverse events reported in association with the use of monoclonal antibody purified factor VIII:C-Monoclate. Semin Hematol 27:16-17, 1990.
6. Chistolini A, Dragoni F, Ferrari A, et al: Intranasal DDAVP: Biological and clinical evaluation in mild factor VIII deficiency. Haemostasis 21:273-277, 1991.
7. Giangrande PLF, Dodd CAF, Gregg-Smith SJ: Knee replacement in hemophilia. Letter. J Bone Joint Surg 76B:166, 1994.
8. Gill JC: Therapy of factor VIII deficiency. Semin Thromb Hemost 19:1-12, 1993.
9. Goldsmith JC, Gordon EM: Treatment of hemophilia B: Serendipitous use of continuous infusion coagulation factor IX. Thromb Res 70:265-267, 1993.
10. Greene WB, DeGnore LT, White GC: Orthopaedic procedures and prognosis in hemophilic patients who are seropositive for human immunodeficiency virus. J Bone Joint Surg 72A:2-11, 1990.
11. Hathaway WE, Christian MJ, Clarke SL, Hasiba U: Comparison of continuous and intermittent factor VIII concentrate therapy in hemophilia A. Am J Hematol 17:85-88, 1984.
12. Hedner U: Experiences with recombinant factor VIIa in haemophiliacs. Curr Stud Hematol Blood Transfus 58:63-68, 1991.
13. Helmer RE, Alperin JB, Yunginger JW, Grant JA: Anaphylactic reactions following infusion of factor VIII in a patient with classic hemophilia. Am J Med 69:953-957, 1980.
14. Hoyer LA: Hemophilia A. N Engl J Med 330:38-47, 1994.
15. Klein U: Production and characterization of recombinant factor VIII. Semin Hematol 28:17-21, 1991.
16. Lethagen S: Desmopressin (DDAVP) and hemostasis. Ann Hematol 69:173-180, 1994.
17. Lethagen S, Egervall K, Berntorp E, Bengtsson B: The administration of desmopressin by nasal spray: A dose-determination study in patients with mild hemophilia A or von Willebrand's disease. Haemophilia 1:97-102, 1995.
18. Lozier J, Santagostino E, Kasper C, Teitel J, Hay CRM: Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Semin Hematol 30:1:10-21, 1993.
19. Lusher JM, Warrier I: Hemophilia A. Hematol Oncol Clin North Am 6:1021-1033, 1992.
20. Manco-Johnson MJ, Nuss R, Geraghty S, Funk S: A prophylactic program in the United States: Experience and issues. Semin Hematol 31:10-12, 1994.
21. Mannucci PM: Desmopressin (DDAVP) for treatment of disorders of hemostasis. Prog Hemost Thromb 8:19-45, 1986.
22. Mannucci PM: Modern treatment of hemophilia: From the shadows towards the tight. Thromb Haemost 70:17-23, 1993.
23. Mannucci PM, Bettaga D, Cattaneo M: The development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP). Br J Haematol 82:87-93, 1992.
24. Mannucci PM, Canciani MT, Rota L, Donovan BS: Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with hemophilia A and von Willebrand's disease. Br J Haematol 47:283-293, 1981.
25. Mannucci PM, Gdovin S, Gringeri A, et al: Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 120:1-7, 1994.
26. Mannucci PM, Santagostino E, Di Bona E, et al: The outbreak of hepatitis A in Italian patients with hemophilia: Facts and fancies. Vox Sang 1:31-35, 1994.
27. Mariani C, Ghirardini A, Bellocco R: Immune tolerance in hemophilia-principal results from the international registry. Thromb Haemost 72:155-158, 1994.
28. Martinowitz U: Stability of factor VIII preparation in continuous infusion. Ann Hematol 68:569-571, 1994.
29. Martinowitz U, Schulman S, Gitel S, et al: Adjusted dose continuous infusion of factor VIII in patients with hemophilia A. Br J Haematol 82:729-734, 1992.
30. Nilsson IM, Berntorp E, Freiburghaus C: Treatment of patients with factor VIII and IX inhibitors. Thromb Haemost 70:56-59, 1993.
31. Nilsson IM, Berntorp E, Ljung R, Lofqvist T, Pettersson H: Prophylactic treatment of severe hemophilia A and B can prevent joint disability. Semin Hematol 31:5-9, 1994.
32. Nilsson IM, Berntorp E, Zettervall O: Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 318:947-950, 1988.
33. Nilsson IM, Jonsson S, Sundqvist SB, Ahlberg A, Bergentz SE: A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: Substitution therapy and surgery in a patient with hemophilia B and antibodies. Blood 58:38-43, 1981.
34. Rose E, Aledort L: Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann Intern Med 114:563-568, 1991.
35. Schulman S, Gitel S, Zivelin A, et al: The feasibility of using concentrates containing F. IX for continuous infusion. Haemophilia 1:103-110, 1995.
36. Steven MM, Small M, Pinkerton L, et al: Non-steroidal anti-inflammatory drugs in haemophilic arthritis. A clinical and laboratory study. Haemostasis 15:204-209, 1985.
37. van den Berg HM, Nieuwenhuis K, Mauser-Bunschoten EP, Roosendaal G: Hemophilia prophylaxis in the Netherlands. Semin Hematol 31:13-15, 1994.
38. Weidel JD, Luck JV, Gilbert M: Total Knee Arthroplasty in the Patient with Hemophilia: Evaluation of the Long-term Results. In Gilbert MS, Greene WB (eds). Musculoskeletal Problems in Hemophilia. New York, National Hemophilia Foundation 152-157, 1989.
39. Weinstein RE, Bona RD, Altman AJ, et al: Severe hyponatremia after repeated intravenous administration of desmopressin. Am J Hematol 32:258-261, 1989.